III - FundFactsheet

Investment Objective: The Company’s objective is to develop a portfolio of unquoted and quoted MedTech companies and to generate capital growth over the long term.

  Dealing Charge  Star Rating Risk Level   12 Month Performance
£10 - MediumMediumMediumMediumMedium 50.65 42.50
Quick Stats Purchase info
Currency: GBX Change on day 0.00% Sector IT VCT Specialist: Health & Biotech Min: -
Bid price: 44.00 YTD return 3.11% Market Value(£m) 3.77 ISA: No
Mid price: 46.40 Yield 0.00% Asset type VCT Discount(-)
/Premium(+)
-27.95
Offer price 48.80 Type ORDN Launch date 19/04/2002 Gearing % -
Performance - View all
Key Chart Instrument 1 mth 6 mths 1 yr 3 yrs
Hygea VCT PLC Ord 1P -7.57% 3.11% 3.11% -30.75%
IT VCT Specialist: Health & Biotech -7.57% 3.11% 3.15% -30.72%
Hygea VCT PLC Ord 1P NAV - 0.62 -6.40 -22.13



Sector Weighting - as at 30/06/17
Region Weighting - click here
Sector % of fund
Telecom, Media & Technology 75.00
Services 21.00
Health Care 2.00
Industrials 2.00
Region Weighting - as at 30/06/17
Sector Weighting - click here
Region % of fund
UK 49.00
Scandinavia 20.00
Europe 14.00
North America 11.00
Germany 6.00

Sector/Region weightings are currently unavailable

Investment Objective

The Company’s objective is to develop a portfolio of unquoted and quoted MedTech companies and to generate capital growth over the long term.

Quick Stats
TIDM code HYG Legal structure VCT Currency GBX
ISIN code GB0031256109 Market Value £3.77 M at 22/06/2018 Price date 22/06/2018
Risk Level MediumMediumMediumMediumMedium Star rating - Pricing freq Daily
Sector IT VCT Specialist: Health & Biotech Valor code - WKN Code -
Bid price 44.00 Mid price 46.40 Offer Price 48.80
Benchmark No Specified Index Yield 0.00% Launch date 19/04/2002
Domicile United Kingdom Asset type ORDN ISA No
NAV 64.40 Discount (-)
/Premium(+)
-27.95 Gearing % -
Purchase & Other Information
Min.investment -
Min.top-up -
Standard (Fund Manager) Initial Charge -
Interactive Investor Initial Charge -
Ongoing Charges 2.20% at 31/12/2017
Compliant -
Dividend dates -
For sale in United Kingdom,
Performance Chart in (GBX)

Shareholder Total Return.

Past performance is not a guide to future performance. Fund performance data doesn’t take into account fees and expenses which are specific to individual plans. Details are available on request.

Cumulative Performance in GBX
  3 mth 6 mth 1 yr 3 yr 5 yr
Investment -7.57% 3.11% 3.11% -30.75% -35.52%
Sector -7.57% 3.11% 3.15% -30.72% -40.02%
Relative to sector 0.00% 0.00% -0.04% -0.03% 4.50%
Rank within sector 1/1 1/1 1/1 1/1 1/1
Quartile 1st 1st 1st 1st 1st
Discrete Annual Performance to Last Quarter End in GBX
  0-12m 12m-24m 24m-36m 36m-48m 48m-60m
Investment 11.56% -6.25% -23.20% 4.17% 4.23%
Sector 11.60% -6.25% -23.20% 4.16% -15.16%
Relative to sector -0.04% 0.00% 0.00% 0.01% 19.39%
Rank within sector 1/1 1/1 1/1 1/1 1/1
Quartile 1st 1st 1st 1st 1st
Performance by Calendar Year in GBX
  YTD 2017 2016 2015 2014
Investment 3.11% -5.26% -9.52% -20.45% -8.97%
Sector 3.11% -5.23% -9.52% -20.45% -8.97%
Relative to sector 0.00% -0.03% 0.00% 0.00% 0.00%
Rank within sector 1/1 1/1 1/1 1/1 1/1
Quartile 1st 1st 1st 1st 1st
Investment Price Movement
12 month high 50.65 (British Pence) 12 month low 42.50 (British Pence)
Risk Statistics
Volatility Alpha Beta Sharpe Tracking Error Information Ratio R2
Investment 14.51 0.36 1.04 -0.02 2.63 0.00 0.97
Asset Weightings as at December 31, 2017
Rank Change Name % Weighting
1 NoChange International Equities 100.00%
  •  Faller
  •  Riser
  •  No change
  • new  New entry
Region Weightings as at June 30, 2017
Rank Change Name % Weighting
1 NoChange UK 49.00%
2 NoChange Scandinavia 20.00%
3 NewEntry Europe 14.00%
4 NewEntry North America 11.00%
5 Faller Germany 6.00%
  •  Faller
  •  Riser
  •  No change
  • new  New entry
Sector Weightings as at June 30, 2017
Rank Change Name % Weighting
1 NewEntry Telecom, Media & Technology 75.00%
2 NoChange Services 21.00%
3 NewEntry Health Care 2.00%
4 NoChange Industrials 2.00%
  •  Faller
  •  Riser
  •  No change
  • new  New entry
Top Holdings as at December 31, 2017
Rank Change Name % Weighting
1 Riser OR PRODUCTIVITY LIMITED 11.10%
2 Riser HALLMARQ VETERINARY IMAGING LIMITED 10.20%
3 Riser INSENSE LIMITED 4.60%
4 NewEntry SCANCELL HLDGS PLC 4.20%
5 Riser IMMUNOBIOLOGY LIMITED 2.00%
6 Riser ARECOR LIMITED 1.90%
7 Faller MICROARRAY LIMITED 1.80%
8 NewEntry OMEGA DIAGNOSTICS GROUP PLC 1.80%
9 Faller EXOSECT LIMITED 1.40%
Total 39.00%
  •  Faller
  •  Riser
  •  No change
  • new  New entry